SciSparc Ltd. Releases Interim Financial Results for H1 2025
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SciSparc Ltd. ( (SPRC) ) has issued an update.
On November 18, 2025, SciSparc Ltd. released its unaudited consolidated interim financial statements for the first half of 2025. The report provides insights into the company’s financial position as of June 30, 2025, including details on assets, liabilities, and equity. This financial disclosure is crucial for stakeholders to assess the company’s financial health and operational performance during the period, which may influence future investment decisions.
More about SciSparc Ltd.
SciSparc Ltd. is a company based in Tel Aviv, Israel, operating in the biotechnology industry. The company focuses on developing therapies for the treatment of disorders related to the central nervous system, leveraging cannabinoid pharmaceuticals.
Average Trading Volume: 4,714,491
Technical Sentiment Signal: Sell
Current Market Cap: $3.89M
For a thorough assessment of SPRC stock, go to TipRanks’ Stock Analysis page.
